Found 7 results
Filters: Keyword is Radiopharmaceuticals  [Clear All Filters]
2019
Seligman L, Kovanlikaya I, Pisapia DJ, Naeger DM, Magge R, Fine HA, Chiang GC.  2019.  Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.. AJR Am J Roentgenol. 212(4):883-891.
2018
Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA.  2018.  Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.. PLoS One. 13(8):e0201289.
Pillai RLI, Malhotra A, Rupert DD, Weschler B, Williams JC, Zhang M, Yang J, J Mann J, Oquendo MA, Parsey RV et al..  2018.  Relations between cortical thickness, serotonin 1A receptor binding, and structural connectivity: A multimodal imaging study.. Hum Brain Mapp. 39(2):1043-1055.
2017
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.. PLoS One. 12(10):e0185926.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.. Neurology. 89(13):1382-1390.
2014
Mosconi L, Murray J, Davies M, Williams S, Pirraglia E, Spector N, Tsui WH, Li Y, Butler T, Osorio RS et al..  2014.  Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study.. BMJ Open. 4(6):e004850.
2010
Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N, NĂ¥gren K, Williams S et al..  2010.  Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.. Proc Natl Acad Sci U S A. 107(13):5949-54.